Skip to main content
    D

    DexCom Inc (DXCM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $87.71
    +4.24 (+5.08%)

    Market Cap: $31.50B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(34/39)
    Avg Surprise
    +51.83%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.67
    Range$0.62 - $0.72
    23 analysts
    EPS RevisionsNo revisions (7d)
    7
    9
    30d
    EPS Estimate DriftChange to current
    90d ago$0.67-0.1%
    60d ago$0.67+0.3%
    30d ago$0.67+0.3%
    7d ago$0.67+0.4%
    Current$0.67
    Revenue Consensus
    $1.3B
    Range$1.3B - $1.3B
    25 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.91
    Range$0.70 - $1.00
    26 analysts
    Revenue Consensus
    $1.4B
    Range$1.4B - $1.5B
    27 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.91---
    Sep 26EST
    		-$0.67---
    Jun 26
    Reported Jul 30
    		$0.70$0.61+14.75%Beat+45.8%
    Mar 26
    Reported Apr 30
    		$0.56$0.47+19.15%Beat+75.0%
    Dec 25
    Reported Feb 12
    		$0.68$0.65+4.62%Beat+51.1%
    Sep 25
    Reported Oct 30
    		$0.61$0.57+7.02%Beat+35.6%
    Jun 25
    Reported Jul 30
    		$0.48$0.44+9.09%Beat+11.6%
    Mar 25
    Reported May 1
    		$0.32$0.33-3.03%Miss+0.0%
    Dec 24
    Reported Feb 13
    		$0.45$0.50-10.00%Miss-10.0%
    Sep 24
    Reported Oct 24
    		$0.45$0.43+4.65%Beat-10.0%
    Jun 24
    Reported Jul 25
    		$0.43$0.39+10.26%Beat+26.5%
    Mar 24
    Reported Apr 25
    		$0.32$0.27+18.52%Beat+88.2%
    Dec 23
    Reported Feb 8
    		$0.50$0.43+16.28%Beat+47.1%
    Sep 23
    Reported Oct 26
    		$0.50$0.33+51.52%Beat+78.6%
    Jun 23
    Reported Jul 27
    		$0.34$0.23+47.83%Beat+100.0%
    Mar 23
    Reported Apr 27
    		$0.17$0.15+13.33%Beat+112.5%
    Dec 22
    Reported Feb 9
    		$0.34$0.28+21.43%Beat+100.0%
    Sep 22
    Reported Oct 27
    		$0.28$0.24+16.67%Beat+27.3%
    Jun 22
    Reported Jul 28
    		$0.17$0.19-10.53%Miss-10.5%
    Mar 22
    Reported Apr 28
    		$0.08$0.13-38.46%Miss+0.0%
    Dec 21
    Reported Feb 10
    		$0.17$0.21-19.05%Miss-26.1%
    Sep 21
    Reported Oct 28
    		$0.22$0.16+37.50%Beat-8.3%
    Jun 21
    Reported Jul 29
    		$0.19$0.11+72.73%Beat-5.0%
    Mar 21
    Reported Apr 29
    		$0.08$0.07+14.29%Beat-27.3%
    Dec 20
    Reported Feb 11
    		$0.23$0.23+0.00%Beat-20.7%
    Sep 20
    Reported Oct 27
    		$0.24$0.16+50.00%Beat+50.0%
    Jun 20
    Reported Jul 28
    		$0.20$0.09+122.22%Beat+900.0%
    Mar 20
    Reported Apr 28
    		$0.11$0.04+175.00%Beat+1200.0%
    Dec 19
    Reported Feb 13
    		$0.29$0.18+61.11%Beat+107.1%
    Sep 19
    Reported Nov 6
    		$0.16$0.05+220.00%Beat+300.0%
    Jun 19
    Reported Jul 31
    		$0.02$0.01+100.00%Beat+200.0%
    Mar 19
    Reported May 1
    		$-0.01N/A+75.00%Beat+87.5%
    Dec 18
    Reported Feb 21
    		$0.14$0.04+250.00%Beat+366.7%
    Sep 18
    Reported Nov 6
    		$0.04$-0.02+300.00%Beat+500.0%
    Jun 18
    Reported Aug 1
    		$-0.02$-0.04+50.00%Beat+50.0%
    Mar 18
    Reported May 2
    		$-0.08$-0.09+11.11%Beat+33.3%
    Dec 17
    Reported Feb 27
    		$0.03$0.01+200.00%Beat+250.0%
    Sep 17
    Reported Nov 1
    		$-0.01N/A+75.00%Beat-
    Jun 17
    Reported Aug 1
    		$-0.04$-0.06+33.33%Beat-
    Mar 17
    Reported May 2
    		$-0.12$-0.12+0.00%Beat-
    Dec 16
    Reported Feb 28
    		$-0.02$-0.02+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio34.40EV/EBITDA21.80x
    Price/FCF23.86xFCF Yield4.19%
    Profitability
    Profit Margin20.10%Operating Margin24.30%
    ROE38.50%ROIC25.87%
    Financial Health
    Debt/Equity0.47xInterest CoverageN/A
    Current Ratio1.73xQuick Ratio1.43x
    Trading Statistics
    Beta1.48Avg Volume3.91M
    52-Week High$92.5952-Week Low$54.11

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$85.06
    SMA 20$86.32
    SMA 50$87.49
    SMA 200$73.87
    EMA 10$85.48
    EMA 20$85.86
    EMA 50$84.96
    EMA 200$76.98

    MACD

    Line: -0.39Signal: -0.38Hist: -0.01

    ADX

    ADX: 11.0+DI: 19.6-DI: 17.2

    Aroon & PSAR

    Aroon Up32.0
    Aroon DownN/A
    PSAR$88.43

    Bollinger Bands

    Upper Band$90.03
    Lower Band$82.60
    %B Position860%(Upper)
    Band Width0.69

    RSI (14-Day)

    Neutral
    55.3

    Momentum Oscillators

    Stoch %K50.7
    Stoch %D39.1
    Williams %R-3.4
    ROC (10d)1.7%
    Momentum1.48
    CCI (20d)34.7
    MFI (14d)42.4

    Volatility Measures

    ATR (14d)$2.43(2.8%)
    StdDev (20d)1.86
    Hist Vol29.3%(Moderate)

    Volume Flow

    VWAP$87.01
    OBV99.5M
    AD Line31.8M
    CMF (20d)0.143

    Volume Metrics

    Avg Vol (20d)4.0M
    Vol Ratio1.1x
    VWMA (20d)$86.91

    Pivot Points

    R3$88.21
    R2$87.20
    R1$85.33
    Pivot Point$84.32
    S1$82.45
    S2$81.44
    S3$79.57

    Advanced Oscillators

    TSI-5.56
    Ultimate Osc55.5
    KST-31.33

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.31B$1.19B$1.26B$1.21B$1.16B$1.04B$1.11B$994.20M$1.00B$921.00M$1.03B$975.00M
    Cost of Revenue$478.40M$441.60M$466.90M$477.90M$468.30M$447.00M$457.70M$400.40M$377.60M$359.10M$377.90M$351.70M
    Gross Profit$830.00M$750.30M$792.70M$731.40M$688.80M$589.00M$655.80M$593.80M$626.70M$561.90M$656.60M$623.30M
    Operating Expenses$511.70M$495.00M$469.70M$488.90M$476.20M$455.30M$466.90M$441.80M$468.70M$460.80M$439.70M$417.80M
    R&D$153.00M$145.30M$148.20M$157.50M$148.20M$145.20M$139.50M$135.40M$136.00M$141.50M$136.10M$131.40M
    SG&A$358.70M$349.70M$321.50M$331.40M$328.00M$310.10M$327.40M$306.40M$332.70M$319.30M$303.60M$286.40M
    Operating Income$318.30M$255.30M$323.00M$242.50M$212.60M$133.70M$188.90M$152.00M$158.00M$101.10M$216.90M$205.50M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$800,000$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$317.50M$269.50M$340.70M$352.30M$241.10M$154.30M$211.30M$177.40M$187.80M$132.50M$246.20M$240.40M
    Income Tax Expense$68.40M$70.00M$73.40M$68.50M$61.30M$48.90M$59.60M$42.80M$44.30M$-13,900,000$-10,100,000$119.70M
    Net Income$249.10M$199.50M$267.30M$283.80M$179.80M$105.40M$151.70M$134.60M$143.50M$146.40M$256.30M$120.70M
    EBITDA$385.70M$336.60M$405.90M$415.90M$304.10M$214.30M$269.10M$232.70M$239.90M$185.00M$298.70M$288.60M
    EBIT$317.50M$269.50M$340.70M$352.30M$241.10M$154.30M$211.30M$177.40M$187.80M$132.50M$246.20M$240.40M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DXCM

    News

    A Look at DexCom Inc (DXCM) After 5.1% Gain -- GF Value $103.59 vs Price $87.71

    DexCom Inc (DXCM) shares rose 5.1% to $87.71, trading significantly below its GF Value™ of $103.59, suggesting it is undervalued. The company boasts a strong GF Score™ of 95/100...

    GuruFocus•10/15/26•Bullish

    Dexcom stock rises 4.14 percent to EUR 77.90, 35.05 percent below average volume

    Dexcom stock increased by 4.14% to EUR 77.90 on October 15, 2026, trading 35.05% below its average volume. This rise comes after Mizuho raised its price target for Dexcom to USD 100.00. Investors are now looking forward...

    ad-hoc-news.de•10/15/26•Bullish

    Dexcom stock rises 4.14 percent to EUR 77.90, 35.05 percent below average volume

    Dexcom stock increased by 4.14 percent to EUR 77.90, trading 35.05 percent below its average volume. Mizuho raised its price target for Dexcom to USD 100.00...

    ad-hoc-news.de•10/15/26•Bullish

    TD Cowen keeps USD 15.00 target for Senseonics stock

    TD Cowen has maintained its Buy rating and USD 15.00 price target for Senseonics Holdings, indicating a potential 45.73 percent upside from its October 15...

    ad-hoc-news.de•10/15/26•Neutral

    Freedom Capital sets USD 36.00 target for HealthStream stock

    Freedom Capital has initiated coverage on HealthStream (HSTM) with a Hold rating and a USD 36.00 price target. This target is 7.05 percent higher than the Nasdaq price of USD 33.63. The article highlights HealthStream's...

    ad-hoc-news.de•10/15/26•Neutral

    DXCM Valuation and Fair Value

    P/E
    34.4x
    Forward P/E
    28.3x
    EV/EBITDA
    21.8x
    P/FCF
    23.9x
    PEG
    1.4x
    P/B
    12.8x
    See GNG's fair value

    DXCM Profitability: Margins, ROIC and FCF

    Gross margin
    62.5%
    Operating margin
    24.3%
    Net margin
    20.1%
    ROIC
    25.9%
    ROE
    38.5%
    FCF margin
    28.3%
    FCF yield
    4.2%

    DXCM Competitors

    CompanyTicker
    Mettler-Toledo International IncMTD
    GE HealthCare Technologies Inc.GEHC
    ResMed IncRMD
    Zoetis IncZTS
    Royalty Pharma PlcRPRX
    West Pharmaceutical Services IncWST
    Biogen IncBIIB
    Laboratory Corporation of America HoldingsLH

    Sector: Healthcare

    DXCM Analyst Ratings

    Consensus
    Buy
    Analysts
    28
    Strong Buy
    3
    Buy
    22
    Hold
    3
    Sell
    0
    Strong Sell
    0

    DXCM Bull Case vs Bear Case

    Bull case

    • DXCM earns a 25.9% return on invested capital.
    • DXCM converts 28.3% of revenue into free cash flow.
    • DXCM has a 20.1% net profit margin.

    DXCM Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    5.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.67
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    7 up, 9 down

    Frequently Asked Questions About DXCM

    Does DXCM pay dividends?

    DexCom Inc (DXCM) does not currently pay a regular dividend.

    What is DXCM's P/E ratio?

    DexCom Inc has a price-to-earnings (P/E) ratio of 34.40.

    What is DXCM's market cap?

    DexCom Inc (DXCM) has a market capitalization of $31.50B with a current stock price of $87.71.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In